Orthofix Medical Inc. (OFIX) Operating Margin
- Operating margin · 12 months: Value -4.70%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -4.70% | Operating income / revenue. Period ending 2026-06-30. $-39.12M ÷ $833.19M × 100 ≈ -4.70% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -39.12M USD | Operating Income (Loss) |
| Revenue | 833.19M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 239.07M USD | Cost of Goods and Services Sold |
| Research and development | 61.41M USD | Research and Development Expense |
| Selling, general and administration | 557.80M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-39.12M | $833.19M | $239.07M | $61.41M | $557.80M | -4.70% |
| 2026-03-31 | $-46.99M | $825.37M | $241.43M | $61.40M | $556.26M | -5.69% |
| 2025-12-31 | $-81.43M | $822.31M | $256.30M | $65.85M | $554.33M | -9.90% |
| 2025-09-30 | $-93.40M | $818.06M | $259.54M | $69.28M | $554.05M | -11.42% |
| 2025-06-30 | $-95.25M | $809.03M | $263.98M | $71.80M | $536.09M | -11.77% |
| 2025-03-31 | $-104.16M | $804.53M | $264.27M | $73.92M | $533.82M | -12.95% |
| 2024-12-31 | $-84.62M | $799.49M | $253.61M | $73.64M | $532.52M | -10.58% |
| 2024-09-30 | $-91.46M | $784.25M | $250.57M | $73.78M | (m) | -11.66% |
| 2024-06-30 | $-97.01M | $771.65M | $253.26M | $75.04M | (m) | -12.57% |
| 2024-03-31 | $-108.73M | $760.04M | $256.86M | $76.42M | (m) | -14.31% |
| 2023-12-31 | $-139.11M | $746.64M | $260.37M | $80.23M | (m) | -18.63% |
| 2023-09-30 | $-131.84M | $668.46M | $229.64M | $74.44M | (m) | -19.72% |
| 2023-06-30 | $-113.18M | $598.45M | $195.97M | $67.83M | (m) | -18.91% |
| 2023-03-31 | $-69.90M | $529.50M | $160.10M | $61.16M | (m) | -13.20% |
| 2022-12-31 | $-13.27M | $460.71M | $123.54M | $49.06M | (m) | -2.88% |
| 2022-09-30 | $-11.58M | $463.55M | $123.75M | $49.16M | (m) | -2.50% |
| 2022-06-30 | $-6.10M | $461.98M | $121.48M | $49.57M | (m) | -1.32% |
| 2022-03-31 | $-8.48M | $465.30M | $117.32M | $49.94M | (m) | -1.82% |
| 2021-12-31 | $-8.31M | $464.48M | $114.91M | $49.62M | (m) | -1.79% |
| 2021-09-30 | $4.74M | $457.03M | $110.73M | $46.74M | (m) | 1.04% |
| 2021-06-30 | $9.23M | $455.59M | $108.67M | $44.34M | (m) | 2.03% |
| 2021-03-31 | $-16.04M | $407.33M | $104.39M | $39.99M | (m) | -3.94% |
| 2020-12-31 | $-6.27M | $406.56M | $101.89M | $39.06M | (m) | -1.54% |
| 2020-09-30 | $-5.88M | $410.44M | $99.01M | $37.14M | (m) | -1.43% |
| 2020-06-30 | $-28.93M | $412.95M | $97.66M | $35.16M | (m) | -7.01% |
| 2020-03-31 | $-7.48M | $455.67M | $100.31M | $35.37M | (m) | -1.64% |
| 2019-12-31 | $-18.78M | $459.95M | $100.61M | $34.64M | (m) | -4.08% |
| 2019-09-30 | $-10.48M | $459.54M | $100.04M | $34.98M | (m) | -2.28% |
| 2019-06-30 | $12.31M | $457.75M | $99.17M | $36.60M | (m) | 2.69% |
| 2019-03-31 | $17.78M | $453.44M | $96.19M | $35.51M | (m) | 3.92% |
| 2018-12-31 | $30.09M | $453.04M | $96.63M | $33.22M | (m) | 6.64% |
| 2018-09-30 | $35.55M | $448.86M | $94.56M | $32.88M | (m) | 7.92% |
| 2018-06-30 | $41.79M | $442.40M | $94.26M | $30.22M | (m) | 9.45% |
| 2018-03-31 | $42.77M | $439.79M | $94.60M | $29.21M | (m) | 9.72% |
| 2017-12-31 | $40.81M | $433.82M | $93.04M | $29.70M | (m) | 9.41% |
| 2017-09-30 | $30.37M | $425.46M | $92.80M | $28.75M | (m) | 7.14% |
| 2017-06-30 | $30.60M | $418.71M | $88.96M | $28.68M | (m) | 7.31% |
| 2017-03-31 | $19.91M | $413.85M | $88.30M | $28.59M | (m) | 4.81% |
| 2016-12-31 | $21.07M | $409.79M | $87.85M | $28.80M | (m) | 5.14% |
| 2016-09-30 | $21.03M | $405.87M | $85.94M | $28.86M | (m) | 5.18% |
| 2016-06-30 | $16.01M | $408.53M | $89.93M | $28.52M | (m) | 3.92% |
| 2016-03-31 | $23.57M | $405.41M | $89.32M | $28.18M | (m) | 5.82% |
| 2015-12-31 | $9.26M | $396.49M | $86.53M | $26.39M | (m) | 2.33% |
| 2015-09-30 | $5.83M | $392.15M | $86.57M | $25.00M | (m) | 1.49% |
| 2015-06-30 | $8.20M | $391.99M | $87.97M | $25.04M | (m) | 2.09% |
| 2015-03-31 | $9.97M | $392.02M | $91.48M | $24.91M | (m) | 2.54% |
| 2014-12-31 | $17.14M | $402.28M | $98.91M | $24.99M | (m) | 4.26% |
| 2014-09-30 | $3.10M | $407.82M | $111.58M | $24.93M | (m) | 0.76% |
| 2014-06-30 | $-17.50M | $398.69M | $111.37M | $24.72M | (m) | -4.39% |
| 2014-03-31 | $-10.71M | $398.50M | $99.31M | $26.97M | (m) | -2.69% |
| 2013-12-31 | $-5.09M | $400.53M | $102.30M | $26.77M | (m) | -1.27% |
| 2013-09-30 | $26.90M | $411.76M | $94.73M | $26.07M | (m) | 6.53% |
| 2013-06-30 | $61.31M | $426.88M | $95.19M | $26.57M | (m) | 14.36% |
| 2013-03-31 | $70.60M | $446.53M | $87.25M | $26.93M | (m) | 15.81% |
| 2012-12-31 | $89.01M | $462.32M | $86.49M | $28.58M | (m) | 19.25% |
| 2012-09-30 | $81.55M | $582.24M | $137.79M | $30.65M | (m) | 14.01% |
| 2012-06-30 | $83.62M | $584.79M | $139.28M | $29.78M | (m) | 14.30% |
| 2012-03-31 | $80.62M | $582.96M | $138.71M | $26.84M | (m) | 13.83% |
| 2011-12-31 | $32.52M | $578.99M | $139.19M | $25.15M | (m) | 5.62% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $564.71M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $88.99M | $564.37M | $131.72M | $30.35M | (m) | 15.77% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $63.88M | $545.63M | $138.45M | $31.46M | (m) | 11.71% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |